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 23 
Abstract -  24 
Bisnaphthalimides are DNA intercalators of potential use as chemotherpeutics but for which 25 
the range of mechanism of action is only gradually being elucidated. Using human 26 
promyelocytic HL-60 cells, we extend characterisation of the cytotoxicity of 27 
bisnaphthalimidopropylspermidine (BNIPSpd) and examine the relationship with caspase-28 
activity. Within 4h exposure, BNIPSpd (1-10 M) induced significant DNA strand breakage.  29 
Evidence of apoptosis was progressive through the experimental period. Within 6h, BNIPSpd 30 
increased the proportion of cells exhibiting plasma membrane phosphatidylserine exposure.  31 
Within 12h, active caspase expression increased and was sustained with 5 and 10 M 32 
BNIPSpd.  Flow cytometric analysis revealed caspase activity in cells with and without 33 
damaged membranes. By 24 h, 5 and 10 M BNIPSpd increased hypodiploid DNA content 34 
and internucleosomal DNA fragmentation (DNA ladders) typical of the later stages of 35 
apoptosis.  1M BNIPSpd exposure also increased hypodiploid DNA content by 48h. 36 
Polyamine levels decreased by 24 h BNIPSpd exposure. The pan-caspase inhibitor, z-VAD, 37 
significantly decreased DNA degradation (hypodiploid DNA and DNA ladders) and induced 38 
an increase in cell growth. Despite this, cell growth and viability remained significantly 39 
impaired. We propose that BNIPSpd cytotoxicity arises through DNA damage and not 40 
polyamine depletion and that cytotoxicity is dominated by but not dependent upon caspase 41 
driven apoptosis.  42 
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1. Introduction  48 
Naphthalimides and bisnaphthalimides are DNA intercalating agents (e.g. Brana et al., 1993, 49 
2001; Cacho et al., 2003; Kong Thoo Lin et al., 2003; Lv et al., 2009; Tan et al., 2015; Wang 50 
et al., 2016) with compounds comprising these moieties variously being proposed for 51 
exploitation as anti-tumourigenics, anti-microbial or anti-parasitic agents (e.g. Gellerman, 52 
2016; Kong Thoo Lin et al., 2003; Oliveira et al., 2007; Noro et al., 2015; Kopsida et al., 2016 53 
Graca et al., 2016).   Bisnaphthalimides consist of two aromatic naphthalimido rings attached 54 
by a linker chain containing nitrogen atoms. Principally, the intercalations of the naphthalimide 55 
planar aromatic rings between DNA base-pairs distorts the conformation of the DNA backbone 56 
leading to interference with DNA-protein interactions (Hsiang et al., 1989; Brana et al., 1993, 57 
Dance et al., 2005). In addition, particular naphthalimide and bisnaphthalimides have been 58 
variously shown to inhibit toposiomerases directly, exert post- DNA damage effects on DNA 59 
damage signalling pathways, impair DNA repair, or induce lysosomal permeability (Filosa et 60 
al., 2009; Zhu et al., 2009; Chen et al., 2010; Bestwick et al., 2011; Barron et al., 2015; Tan et 61 
al., 2015; Zhang et al., 2016a;).  The ultimate consequence of exposure to (bis-) naphthalimides 62 
in vitro has included cell cycle arrest and apoptosis (Ralton et al., 2009; Liang et al., 2011; Yang 63 
et al., 2011a; Seliga et al., 2013; Zhang et al., 2016a).  64 
 This array of often complementary mechanisms of (bis-)naphthalimide action 65 
influencing tumour cell, microbes and parasite development has continued to encourage their 66 
development as therapeutics. In previous work, we linked bisnaphthalimido propyl fragments 67 
with natural polyamines such as spermine and spermidine (Dance et al., 2005; Kong Thoo Lin 68 
et al., 2000; Pavlov et al., 2001). As neoplastic transformation can be accompanied by elevated 69 
polyamine levels resulting from altered biosynthesis, catabolism and uptake (Basuroy and 70 
Gerner 2006), we hypothesised that the polyamine linker would facilitate uptake of the 71 
bisnaphthalimides into neoplastic cells (Dance et al., 2005). 72 
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 We previously reported that bisnaphthalimidopropylspermine (BNIPSpm) and  73 
bisnaphthalimidopropylspermidine (BNIPSpd) have enhanced aqueous solubility, and are 74 
rapidly and homogeneously distributed within the nuclei of MCF-7 breast carcinoma and 75 
Caco-2 colon adenocarcinoma cells where they cause significant DNA damage and 76 
impairment of DNA base excision repair (Bestwick et al., 2011; Dance et al., 2005). 77 
Moreover, the more cytotoxic of the two, BNIPSpd (Fig 1), induces apoptosis in Caco-2 and 78 
HT-29 colon epithelial cells (Ralton et al., 2009). However, the conservation of the apoptotic 79 
response to BNIPSpd, and the mechanism underlying such response in differing cell types, 80 
has not been established.  Here, following a preliminary report (Kong Thoo Lin et al., 2003), 81 
we provide a detailed assessment of the effects of BNIPSpd on cell growth and cytotoxicity in 82 
HL-60 promyelocytic leukaemia cells, examining the temporal relationship of apoptosis to 83 
DNA damage and polyamine levels and the extent of caspase dependency within overall 84 
BNIPSpd toxicity.  85 
 86 
2. Materials and methods 87 
2.1. Materials 88 
HL-60 cells were purchased from the European Collection of Cell Cultures 89 
(98070106; Public Health England, Salisbury, UK). RPMI medium and foetal calf serum 90 
were from Lonza Sales AG (Verviers, Belgium). Tissue culture flasks were supplied by 91 
Greiner Bio-One Ltd (Gloucesterhire, UK). Active Caspase-3 detection kit, Cell Cycle Plus 92 
DNA Reagent Kit and QC DNA particles were from BD (Oxford, UK). Vybrant FAM 93 
Polycaspases kits, Amplex Red hydrogen peroxide assay kits and DAPI were from Life 94 
Technologies Ltd (Paisley, UK).  The Annexin V-FITC kit and single strand DNA detection 95 
kit were from eBioscience Ltd (Hatfield, UK). Etoposide, camptothecin, dimethylsulfoxide 96 
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(DMSO) and all other reagents were purchased from Sigma-Aldrich Company Ltd (Dorset, 97 
UK) unless stated otherwise. BNIPSpd was synthesised and characterised according to our 98 
previous methods (Kong Thoo Lin and Pavlov 2000). 99 
 100 
2.2. Cell Culture and bisnapthalimidopropyl polyamine exposure 101 
HL 60 cells were cultured in RPMI 1640 medium supplemented with 10 % (v/v) foetal 102 
calf serum, 1% (v/v) non essential amino acids, 2 mM glutamine, 50 g/mL streptomycin and 103 
50 g/mL penicillin. Cells were kept in a humidified (95% relative humidity, RH) incubator 104 
at 37 °C, 5% CO2. BNIPSpd was  solubilized in 20% (v/v) DMSO and cells (5x105 cells mL-105 
1) were incubated with 0.1-10M BNIPSpd (0.02% [v/v] DMSO final concentrations), 0.02 % 106 
(v/v) DMSO or sterile double distilled water for 1-72 h. The chemotherapeutic agents 107 
etoposide (10 M) and camptothecin (4 M) in 0.1% [v/v] DMSO final concentrations, were 108 
used as positive controls to confirm assay function as appropriate. For caspase inhibitor 109 
experiments, cells were pre-incubated with 100 M z-VAD-fmk (in 0.2% v/v DMSO final 110 
concentration) for 1 h at 37°C, 5% CO2, 95%  RH prior to addition of BNIPSpd.  111 
2.3. Cell culture growth and cytotoxicity 112 
Cells were collected by centrifugation (300 g for 5 min, RT), the culture media 113 
removed and the pellet suspended in trypan blue (0.2% w/v final concentration in PBS).  Cells 114 
were counted using a Neubauer haemocytometer (Baur et al., 1975).   115 
 116 
2.4. DNA single strand breaks 117 
 118 
DNA single strand breaks were determined by single cell gel electrophoresis (SCGE) 119 
as described previously (Bestwick et al., 2005). Nucleoids were stained with 4',6-diamidino-120 
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2-phenylindole (DAPI, 5 gmL-1 stock) and scored visually. One hundred images per gel, 121 
(with duplicate gels per slide) were classified according to the intensity of fluorescence in the 122 
nucleoid tail and assigned a value of 0-4 with 0 representing no damage and 4 maximal 123 
damage. Thus, the total damage score can range from 0 to 400. This method of classification 124 
has been extensively validated using computerised image analysis (Duthie et al., 1996).  125 
2.5. Phosphatidylserine exposure and membrane integrity 126 
Exposure of phosphatidylserine at the extracellular surface of the plasma membrane 127 
was determined as previously described (Bestwick and Milne 2006) by FITC-Annexin-V 128 
binding using a commercial assay kit, and the relationship to membrane damage assessed by 129 
co-incubation with propidium iodide (PI) as per the manufacturer’s protocol (eBioscience Ltd, 130 
Hatfield, UK).  131 
2.6. Caspase-3 and pan-caspase  132 
The presence of the active fragment of caspase-3 was analysed by flow cytometry 133 
after cell fixation, permeabilization and labelling with PE-conjugated polyclonal rabbit anti-134 
active caspase-3 (BD, Oxford) as described previously for HL-60 cells (Bestwick and Milne 135 
2006).  Total (pan-) caspase activity relative to maintenance of membrane-integrity was 136 
estimated by measuring fluorescence in cells co-treated with FAM-VAD-FMK polycaspase 137 
reagent (labelling active caspase 1, 3, 4, 5, 6,7, 8, 9)  and propidium iodide according to 138 
manufacturer’s recommendations (Life Technologies Ltd, Paisley, UK). Camptothecin 139 
treatment and mock-(water) treated cells (positive and negative controls respectively), were 140 
used to define active caspase-3 expression or increased pan-caspase activity using Cell Quest 141 
software (BD, Oxford, UK). 10,000 events were recorded.  142 
 143 
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2.7. Apoptosis-associated DNA fragmentation 144 
 145 
 SubG1 (hypodiploid) DNA content was evaluated as described previously (Bestwick 146 
et al., 2007) using a commercial kit (Cycle test plus) according to the manufacturer’s protocol 147 
(BD, Oxford, UK). Flow cytometry of the propidium iodide-stained nuclei was performed 148 
with a flow rate of 12 µL/min and cell cycle distribution selected from linear FL-2 area v. 149 
width plots with doublet discrimination in FL-2. Singlet events, excluding debris, were gated 150 
and 20,000 events were acquired within the gate.  The percentage of cells with DNA content 151 
<2N (sub-G1) was calculated from histograms of linear FL-2 area plots of the singlet gated 152 
region using Cell Quest Software (BD, Oxford, UK) and Mod Fit LT software (Verity 153 
Software House, ME, USA).  A DNA QC Particle Kit (BD, Oxford, UK) was used to verify 154 
instrument linearity, doublet discrimination and cytometer alignment.  155 
 Internucleosomal DNA fragmentation giving rise to the characteristic apoptotic ‘DNA 156 
ladder’, was identified following DNA extraction and separation by agarose gel 157 
electrophoresis as detailed in Bestwick and Milne, (Bestwick and Milne 2006).  158 
2.8 Polyamine extraction and analysis 159 
Cells were treated either with solvent vehicle (DMSO), BNIPSpd or -160 
difluoromethylornithie (DFMO; 5 mM) as a positive control for polyamine changes. Culture 161 
medium from control and BNIPSpd-treated cells were decanted, the cells collected by 162 
centrifugation (1000 g, 5 min, 20 C) and counted using a Neubauer haemocytometer. Cells 163 
were washed with PBS (x2) before being homogenised with perchloric acid (final 164 
concentration 1% v/v) and incubated with internal standard (1,7-diaminoheptane ;20 M for 165 
60 min on ice).  The homogenate was centrifuged at 10000g (C) for 10 minutes and the 166 
supernatant transferred to a fresh container and stored at -20oC. The residual cell pellet and 167 
culture medium were also retained at -20oC. HPLC analysis of polyamine content was carried 168 
out by derivatization with o-phthaldialdehyde (OPA) in the presence of 2-mercaptoethanol as 169 
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described by Seiler and Knodgen (Seiler and Knodgen, 1985).  HPLC was conducted with a 170 
Phenomenex Luna 5 mm, 25 cm x 4.6 mm, C18 HPLC column. Detection of polyamines after 171 
OPA derivatisation was at 345 nm excitation with 455 nm emission filters. Data were 172 
collected and integrated using Waters Empower Software (Waters Yvelines Cedex, France). 173 
2.9. Hydrogen peroxide determination. 174 
Hydrogen peroxide, arising from the interaction of the polyamine analogue with amine 175 
oxidases in bovine serum (Parchment et al., 1990), is a potential confounder of the cellular 176 
response to BNIPSpd. Using the Amplex Red Assay  (Life Technologies Ltd, Paisley, UK), 177 
the level of hydrogen peroxide in complete RPMI 1640 medium containing BNIPSpd (1-50 178 
M) was measured within 5h incubation via the peroxidase catalysed formation of resorufin 179 
(560 nm,Unicam UV/Vis spectrophotometer) . Co-incubations with native or heat denatured 180 
(5 min, 100 C) bovine catalase (Sigma-Aldrich Company Ltd, Dorset, UK; 2.5 g/mL) were 181 
used to confirm detection of hydrogen peroxide.  182 
 183 
2.10 Statistical Analysis 184 
Experiments were conducted a minimum of three times unless stated otherwise. Data 185 
are presented as mean + SD. A P-value of < 0.05 (by student’s t-test) was taken as the 186 
minimum basis for assigning significance. Statistical analysis was conducted using SigmaStat 187 
(Systat, Software Inc. London, UK). 188 
 189 
3. Results 190 
 191 
3.1. Cell growth and cytotoxicity 192 
 193 
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BNIPSpd (1-10 M) caused a significant inhibition (1 M) or cessation (5 and 10 M) 194 
of cell growth (Fig 2A).  Based on trypan blue staining, 5 and 10 M BNIPSpd also exerted  195 
significant cytotoxicity (Fig 2B) within 24 h. Therefore, analysis of the mechanisms 196 
underpinning cytotoxicity was predominantly conducted within the first 24 h of treatment.  197 
 198 
3.2. DNA single strand breaks 199 
DNA single strand breakage was significantly increased after 4h exposure to 1 M-10 M 200 
BNIPSpd and remained significantly increased over control cells after 24h treatment  (Fig. 3).  201 
3.3. Phosphatidylserine exposure and membrane integrity. 202 
 203 
Exposure to BNIPSpd (≥ 1 M) caused a significant increase in the proportion of cells 204 
binding annexin-V-FITC at 6-24 h but remaining recalcitrant to PI staining (Fig 4A and 4B). 205 
This indicates exposure of phosphatidylserine on the external plasma membrane surface in the 206 
absence of membrane damage. In addition, BNIPSpd also induced a significant increase in the 207 
proportion of cells co-labelling with annexin-V-FITC and PI (Fig.4A and B), representing 208 
annexin-V-FITC binding to cells with damaged membranes.  Cells treated with solvent 209 
vehicle alone remained predominantly unlabeled with either annexin-V-FITC or PI (Fig 4A 210 
and B). For all treatments, a residual proportion of cells stained with PI but did not label with 211 
annexin-V-FITC. This represented 2.6 % (+ 0.19) of control cells at 24 h and this increased (P 212 
< 0.05) after treatment with 10 M BNIPSpd (24 h) to14.3 % (+ 3.4). 213 
 214 
3.4. Active caspase-3 expression and pan caspase activity.  215 
Active caspase-3 expression increased during time in culture within negative (DMSO 216 
solvent only treated) control cells but 10M and  5 M BNIPSpd treatment further 217 
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significantly enhanced  and sustained active caspase-3 expression by 4 h and 12h after 218 
exposure respectively (fig 5). A transient but significant increase in caspase-3 was also 219 
observed by 12 h of incubation in 1M BNIPSpd treated cells (Fig. 5).  220 
Focussing on 5 and 10 M BNIPSpd treatment for which there was a more rapid and 221 
sustained active caspase-3 expression (Fig 5), the relationship between general-caspase 222 
activity and membrane damage was flow-cytometrically assessed by combining FAM-VAD-223 
FMK FLICA labelling of active caspases (caspase 1, 3, 4, 5, 6,7, 8, 9) with PI staining to 224 
measure membrane integrity. The median fluorescence intensity, as a marker of overall 225 
caspase activity (Fig 6A)  and the proportion of cells expressing pancaspase activity (Fig 6B) 226 
increased significantly by 8 h of treatment with BNIPSpd. Increased pan-caspase activity was 227 
detected both in cells with intact membranes and in those with compromised membrane 228 
integrity (Fig 6B).  229 
 230 
3.5  ‘Apoptotic’ DNA fragmentation 231 
 232 
A significant increase in the proportion of cells with a subG1 DNA content was 233 
observed after 3 h and 24 h for 10 and 5 M BNIPSpd treatments respectively. A smaller but 234 
nevertheless significant increase in sub G1 DNA content was observed by 48 h with 1 M 235 
BNIPSpd (Fig. 7A). Classical apoptotic internucleosomal DNA fragmentation was not 236 
observed within the first 12 h of BNIPSpd exposure. By 24 h, however, DNA ladders 237 
occurred in cultures treated with ≥ 5 M BNIPSpd (Fig. 7B) and were particularly apparent in 238 
5 M BNIPSpd treated cells 239 
 240 
3.6. Polyamine levels 241 
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No changes to spermine and spermidine levels were observed after 12 h incubation with 1-242 
10M BNIPSpd. BNIPSpd treatment for 24 h resulted in a lowering of spermine and 243 
spermidine levels (Fig 8A and B). Putrescine was not detected in the analysis of either 244 
BNIPSpd treated or untreated cells. 245 
 246 
3.7. Effect of caspase inhibitor on cytotoxicity  247 
To investigate caspase-dependency of BNIPSpd toxicity, cells were pre-treated with the pan 248 
caspase inhibitor z-VAD-FMK, prior to and during exposure to 10 M BNIPSpd. Z-VAD-249 
fmk strongly decreased the intensity of internucleosomal DNA fragmentation and 250 
significantly lowered the increase in sub G1 DNA content (Fig 9 A and B). The anti-251 
proliferative (Fig 9C) and cytotoxic effects (Fig 9D) of BNIPSpd were slightly but 252 
significantly lowered by caspase inhibition. Nevertheless, there remained a highly significant 253 
reduction in cell growth (Fig 9C) and high levels of cytotoxicity (Fig 9D) in response 254 
BNIPSpd.  255 
 256 
3.8. Culture medium hydrogen peroxide content 257 
The influence of BNIPSpd on the concentration of hydrogen peroxide in serum-supplemented 258 
culture media, which may be a confounding factor in BNIPSpd toxicity, was established via 259 
the Amplex Red assay. Endogenous hydrogen peroxide present in the test mixture acts as a 260 
co-substrate in the oxidation of amplex red via exogenously added horseradish peroxidase and 261 
leads to the formation of resorufin. No significant change in hydrogen peroxide content was 262 
observed up to 10 M BNIPSpd (the maximum concentration used in the cytotoxicity assays) 263 
but a significant increase in resorufin absorbance was observed with 50 M BNIPSpd. This 264 
increase was sensitive to the presence of native catalase, confirming the potential for elevated 265 
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levels of exogenous hydrogen peroxide at these higher, but here, not experimentally relevant 266 
BNIPSpd incubations (Fig 10).    267 
 268 
4. Discussion 269 
Within a series of novel bisnaphthalimido-polyamine compounds, the spermidine-containing 270 
BNIPSpd exerts the dominant cytotoxicity against MCF-7 breast carcinoma (Dance et al., 271 
2005) and Caco-2 colon adenocarcinoma cells (Bestwick et al., 2011).  Cytotoxicity is 272 
preceded by DNA single strand breakage (Dance et al., 2005; Bestwick et al., 2011). Here, 273 
BNIPSpd also rapidly caused DNA single strand breaks in HL-60 cells and a progressive 274 
increase in features typical of a classical apoptotic progression towards cell death. Within 275 
24h, BNIPSpd exposure was associated with early externalisation of plasma membrane 276 
phosphatidylserine, a progressive increase in active caspase-3 and pan caspase activity and 277 
DNA fragmentation (hypodiploid DNA content and internucleosomal DNA fragmentation), 278 
all features indicative of apoptosis (Elmore 2007; Darzynkiewicz and Li 1996; Kohler et al., 279 
2002; Otsuki et al., 2003). 280 
Both the naphthalimide and polyamine moiety of BNIPSpd may trigger apoptosis 281 
(Basuroy and Gerner 2006; Casero and Woster, 2001; Brana et al., 2001; Liang et al., 2011). 282 
For the (bis)naphthalimide moiety,  DNA intercalation and the effect on DNA replication and 283 
integrity is proposed as the primary mode of action (Kong Thoo Lin  and Pavlov, 2000; 284 
Dance et al., 2005) but the presence of the polyamine moiety might also suggest an influence 285 
on cellular polyamine levels and metabolism (Morgan, 1999; Wallace and Niiranen, 2007; 286 
Schipper et al., 2000; Basuroy et al., 2006).  The naturally occurring polyamines putrescine, 287 
spermidine and spermine represent a potential link between proliferation and cell death 288 
(Schipper et al., 2000; Moschou et al., 2014)  and polyamine analogues may influence cell 289 
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survival by effects on  cellular polyamine pools (Zou et al., 2004). However, polyamines 290 
exhibit a complex relationship to cell survival and exert both negative and positive regulatory 291 
effects on apoptosis  (e.g. Milovic and Turchanowa, 2003; Stefanelli et al., 2001; Yuan et al., 292 
2002; Zou et al., 2004) . 293 
Here, DNA single strand breakage occurred within the first 4 h of treatment with 294 
BNIPSpd. This parallels or occurs in advance of the earliest detection of apoptosis markers. 295 
Conversely, there was no change in polyamine level within the first 12 h of exposure. Thus, 296 
while polyamine levels do decline during cell death, on a temporal basis polyamines do not 297 
appear to be involved in induction of DNA damage or initiation of apoptosis within 298 
BNIPSpd-treated HL60 cells. This contrasts with observations in Caco-2 and HT-29 cells 299 
where polyamine levels are significantly affected both at the pro-apoptotic BNIPSpd dosage 300 
range (>0.5 M) and by non- toxic BNIPSpd exposures ( > 0.01 M) (Ralton et al., 2009).  301 
Based on our observations of the timing of BNIPSpd- induced DNA damage relative to 302 
changes in polyamine levels, we propose that it is the effect of the bisnaphthalimide moiety 303 
on DNA (Dance et al., 2005; Bestwick et al., 2011) that is the consistent early-induced 304 
phenomenon associated with BNIPSpd-cell interactions. 305 
However, when considering the extent of cytotoxicity and DNA strand breakage at 1 306 
M BNIPSpd exposure, the degree of DNA damage does not predict the eventual magnitude 307 
of apoptosis or overall toxicity, with limited toxicity despite considerable DNA damage and 308 
inhibition of proliferation. Inhibitory effects on DNA repair activity may predominate at these 309 
BNIPSpd concentrations (Bestwick et al., 2011). The influence of BNIPSpd and other 310 
analogues on cell growth and survival regulation at low-cytotoxic and sub-cytotoxic dosages 311 
are currently under investigation.    312 
In addition to the direct effect of BNIPSpd on cell survival, we considered whether 313 
amine oxidases in the culture medium may promote hydrogen peroxide generation in the 314 
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presence of the spermidine analogue (Bitonti et al., 1990; Parchment et al., 1990). No increase 315 
in hydrogen peroxide was detected in culture medium incubated with BNIPSpd at the 316 
concentrations employed. Consequently, hydrogen peroxide generation from BNIPSpd 317 
addition in the media appears not to be a factor in BNIPSpd toxicity in this culture system. 318 
However, whether BNIPSpd toxicity involves oxidative stress intracellularly has not been 319 
determined.  320 
Given the timing of DNA strand break detection, we suggest that the intrinsic 321 
mitochondrial pathway for apoptosis, initiated by DNA damage as a likely primary route for 322 
orchestrating toxicity. Given the p53 null status of HL60 (Leroy et al., 2014), this is not 323 
dependent on p53 though be mediated through a functional substitution such as via p73 (e.g. 324 
Chakraborty et al., 2010), a member of the p53 protein family (Chekova et al., 2018). 325 
Although BNIPSpd toxicity was associated with features typical of a classical apoptosis, the 326 
presence of a proportion of cells exhibiting membrane damage concomitant with or in 327 
advance of apoptotic markers also suggests a more heterogeneous cell death process occurs as 328 
part of the overall BNIPSpd-induced toxicity. Cytotoxicity of BNIPSpd in MCF-7 cells 329 
(Dance et al., 2005) which do not express Caspase-3 (Janicke, 2009) indicates a non-caspase-330 
3 dependency for toxicity.  Here, z-VAD-FMK was used to investigate general caspase-331 
relationship to cytotoxicity. While abolishing apoptotic DNA fragmentation, z-VAD-FMK 332 
failed to rescue the majority of cells from the anti-proliferative and cytotoxic effects of 333 
BNIPSpd. Many cytotoxic chemotherapeutic drugs demonstrate non-caspase dependency 334 
(e.g. camptothecin, doxorubicin, paclitaxel; Broker et al., 2005). Caspase inhibition can 335 
induce a switch from classical apoptosis to alternate cell death processes or an alteration of 336 
dominance of a cell death mechanism paralleling apoptosis induction. The range of changes to 337 
cell death mode has included autophagy, “mitotic catastrophy”, necrosis-like programmed cell 338 
death (e.g. necroptosis; Zhang et al., 2016b) and more traditional necrosis (Broker et al., 339 
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2005). For example, caspase inhibition switches doxorubicin-induced cytotoxicity within 340 
SKN-SH neuroblastoma cells from apoptosis to senescence (Rebbaa et al., 2003), whereas Z-341 
VAD-FMK promotes a shift from apoptosis to necrosis during corneal scrape-induced 342 
keratocyte death (Kim et al., 2000).  For many of these outcomes, the mechanistic inter-343 
relationship has yet to be comprehensively established.  Caspase inhibition might also 344 
increase the role of non-caspase dependent apoptotic-like processes, for example involving 345 
apoptosis inducing factor (AIF). AIF has been implicated recently in mono-naphthalimide 346 
spermidine-induced apoptosis in HeLa cells (Yang et al., 2011b).  We hypothesise that the 347 
many influences of (bis)naphthalimide-containing compounds on processes linked to cell 348 
proliferation and genomic integrity (Filosa et al., 2009; Zhu et al., 2009; Chen et al., 2010; 349 
Bestwick et al., 2011; Yang et al., 2011a; Li et al., 2013; Seliga et al., 2013; Shen et al., 2013) 350 
renders them capable of inducing a range of  cell death mechanisms as well as multiple point 351 
of provocation of apoptosis.  352 
Here HL-60 cells are utilised but comparison to multiple cell types (and ultimately the 353 
use of organoid systems) will help to confirm the universality and mechanistic variations of 354 
BNIPSpd-cell-interactions in vitro. Nevertheless, the effects observed in Caco-2 and HT-29 355 
colon adenocarcinoma cell cultures (Ralton et al. 2009)  point to key conserved outcomes in 356 
terms of apoptosis features and early induction of DNA damage post exposure (Bestwick et al., 357 
2011)  but, as discussed above, significant differences are apparent for the effect on cellular 358 
polyamine content (Ralton et al., 2009). Significantly, previous work on characterising 359 
BNIPSpd and related bisnaphthalimide-polyamine compounds (Dance et al., 2005) on the form 360 
of toxicity within caspase-3 deficient but p53 active MCF-7 cells (e.g. Zhao et al., 2017) would 361 
be a useful component of comparisons on BNIPSpd activity within differing apoptotic 362 
regulator-competent backgrounds. 363 
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In conclusion, BNIPSpd cytotoxicity in HL60 cells occurs primarily through an 364 
apoptotic-like process, potentially initiated by bisnaphthalimide-induced DNA damage and 365 
within a temporal framework involving phosphatidylserine exposure, caspase activation and 366 
DNA fragmentation.  However, caspase inhibition does not rescue cells from BNIPSpd 367 
toxicity. While it remains to be established whether this adds to exploitability for 368 
chemotherapy or represents a confounder to the therapeutic development of this 369 
bisnaphthalimidopropyl polyamine series, caspase-independent cell death provides further 370 
evidence of the heterogeneity in the cytotoxic response to (bis)naphtahlimides.  371 
 372 
 373 
  374 
 17
Acknowledgments 375 
The authors wish to thank Viv Buchan of the RINH Analytical Division for polyamine 376 
analysis and gratefully acknowledges the Robert Gordon University, The Scottish 377 
Government (RESAS-polyamine ) and the Royal Society of Chemistry for financial support. 378 
 379 
Conflict of interest statement: There are no conflicts of interest associated with this work.  380 
  381 
 18
References 382 
Barron, GA, Goua, M, Kuraoka, I., Bermano, G., Iwai, S, Lin PKT., 2015. 383 
Bisnaphthalimidopropyl diaminodicyclohexylmethane (BNIPDaCHM) bisintercalates to 384 
DNA and induces DNA damage and repair instability in triple negative breast cancer cells via 385 
p21. Chemico-Biological Interactions 242, 307-315 386 
Basuroy, U.K., Gerner, E.W., 2006. Emerging concepts in targeting the polyamine metabolic 387 
pathway in epithelial cancer chemoprevention and chemotherapy. Journal of Biochemistry 388 
139, 27-33.  389 
Baur, H., Kasperek, S., Pfaff, E., 1975. Criteria of viability of isolated liver cells. Hoppe-390 
Seylers Zeitschrift fur Physiologische Chemie 356, 827-838.  391 
Bestwick, C.S., Milne, L., 2006. Influence of galangin on HL-60 cell proliferation and 392 
survival. Cancer Letters 243, 80-89. 393 
Bestwick, C.S., Milne, L., Pirie, L., Duthie, S.J., 2005. The effect of short term kaempferol 394 
exposure on reactive oxygen levels and integrity of human (HL60) leukaemic cells. 395 
Biochimica Biophysica Acta –Molecular Basis of Disease1740, 340-349. 396 
Bestwick, C.S., Milne, L., Duthie, S.J., 2007. Kaempferol induced inhibition of HL-60 cell 397 
growth results from a heterogeneous response, dominated by cell cycle alterations. Chemico-398 
Biological Interactions 3, 179-191. 399 
Bestwick,  C.S., Ralton, L.D., Milne, L., Kong Thoo Lin. P., Duthie, S.J., 2011. The influence 400 
of bisnaphthalimidopropyl-polyamines on DNA instability and repair in Caco-2 colon 401 
epithelial cells. Cell Biology and Toxicology 27, 455-463.   402 
 19
Brana, M.F., Castellano, J.M., Moran, M., Perez De Vega, M.J., Romerdahl, C.R., Qian, 403 
X.D., Bousquet, P.F., Emling, F., Schlick, E., Keilhauer, G., 1993. Bis-naphthalimides: a new 404 
class of antitumor agents. Anti-Cancer Drug Design 8, 257-268. 405 
Brana, M.F., Cacho, M., Gradillas, B., De Pascual-Teresa, B., Ramos, A., 2001. Intercalators 406 
as anticancer drugs. Current Pharmaceutical Design 17, 1745–1780. 407 
Broker, L.E., Kruyt, F.A.E., Giaccone, G., 2005. Cell death independent of caspases: A 408 
review. Clin. Cancer Res. 11, 3155-3162. 409 
Bitonti, A.,J., Dumont, J.A., Buch, T.L., Stemerick, D.M., Edwards, M.L., McCann, P.P. 410 
1990. Bis(benzyl)polyamine analogs as novel substrates for polyamine oxidase. J. Biol. 411 
Chem. 265, 382-388. 412 
Cacho, M., Ramos, A., Dominguez, M.T., Pozuelo, J.M., Abradelo, C., Rey-Stolle, M.F., 413 
Yuste, M., Carrasco, C., Bailly, C., 2003. Synthesis, biological evaluation and DNA binding 414 
properties of novel mono and bisnaphthalimides. Organic and Biomolecular Chemistry1, 648-415 
654.  416 
Casero, R.A., Woster, P.M.. 2001.Terminally alkylated polyamine analogues as 417 
chemotherapeutic agents. J. Med. Chem. 44,1-26. 418 
Cechova J, Coufal J, Jagelska E.B., Fojta M., Vaclav Brazda V., 2018. p73, like its p53 419 
homolog, shows preference for inverted repeats forming cruciform. PLoS ONE 13(4): 420 
e0195835. 421 
Chakraborty J.,  Banerjee S., Ray P., Hossain D.M.S., Bhattacharyya S., Adhikary A., 422 
2010.Gain of Cellular Adaptation Due to Prolonged p53 Impairment Leads to Functional 423 
 20
Switchover from p53 to p73 during DNA Damage in Acute Myeloid Leukemia Cells. J.Biol 424 
Chem, 285, 33104-33112 425 
Chen, Z., Liang, X., Zhang, H.Y., Xie, H., Liu, J., Xu, Y., Zhu, W., Wang, Y., Wang, X., Tan, 426 
S., Kuang, D., Qian, X.,  2010. A new class of naphthalimide-based antitumor agents that 427 
inhibit topoisomerase II and Induce lysosomal membrane permeabilization and apoptosis. J. 428 
Med.Chem. 53,  2589-2600. 429 
Dance, A-M., Ralton, L., Fuller, Z., Bestwick, C.S., Milne, L., Duthie, S., Kong Thoo Lin, P., 430 
2005. Synthesis and biological activities of bisnaphthalimido polyamines derivatives: 431 
cytotoxicity, DNA binding, DNA damage and drug localization in breast cancer MCF 7 cells. 432 
Biochemical Pharmacology 69, 19-27.  433 
Darzynkiewicz, Z., Li, X., 1996. Measurement of cell death by flow cytometry, in: Cotter, 434 
T.G., Martin, S.J. (Eds.),  Techniques in Apoptosis. Portland Press, London, pp. 71-106. 435 
Duthie, S.J., Ma, A., Ross, M.A., Collins, A.R., 1996. Antioxidant supplementation decreases 436 
oxidative damage in human lymphocytes. Cancer Research 56, 1291-1295. 437 
Elmore, S., 2007. Apoptosis: A review of programmed cell death. Toxicologic Pathology 438 
35,495-516. 439 
Filosa, R., Peduto, A., Di Micco, S., De Caprariis, P., Festa, M., Petrella, A., Capranico, G., 440 
Bifulco, G., 2009. Molecular modelling studies, synthesis and biological activity of a series of 441 
novel bisnaphthalimides and their development as new DNA topoisomerase II inhibitors. 442 
Bioorganic and Medicinal Chemistry 17, 13 – 24. 443 
Gellerman, G (2016) Recent Developments in the Synthesis and Applications of Anticancer 444 
Amonafide Derivatives. A Mini Review. Letters in Drug Design and Discovery, 13: 47-63. 445 
 21
Graça N., Gaspar L., Costa D., Loureiro I., Kong Thoo Lin P., Ramos I., A., Pemberton I., 446 
MacDougall J., Tavares J., Cordeiro-da-Silva A., 2016. Bisnaphthalimidopropyl Derivatives 447 
as New Leads AgainstTrypanosoma brucei. Antimicrob Agents Chemother. 60(4):2532-6.doi: 448 
10.1128/AAC.02490-15 449 
Hsiang, Y.H., Jiang, J.B., Liu, L,F., 1989. Topoisomerase II-mediated DNA cleavage by 450 
amonafide and its structural analogues.  Molecular Pharmacology 36,  371-376.  451 
Janicke, R.U., 2009. MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer 452 
Res. Treat. 117, 219-221. 453 
Kim, W-J., Mohan, R.R., Mohan, R.R., Wilson, S.E. 2000. Caspase inhibitor z-VAD-FMK 454 
inhibits keratocyte apoptosis, but promotes keratocyte necrosis, after corneal epithelial scrape. 455 
Exp. Eye. Res. 71, 225-232. 456 
Kohler, C., Orrenius, S., Zhivotovsky, B., 2002. Evaluation of caspase activity in apoptotic 457 
cells. Journal of Immunological Methods 265, 97-110. 458 
Kong Thoo Lin, P., Pavlov, V.A., 2000. The synthesis and in vitro cytotoxic studies of novel 459 
bis-naphthalimidopropyl polyamine derivatives. Bioorganic and Medicinal Chemistry Letters 460 
10, 1609-1612. 461 
Kong Thoo Lin. P., Dance, A.M., Bestwick, C., Milne, L., 2003.The biological activities of 462 
new polyamine derivatives as potential therapeutic agents Biochem. Soc. Trans. 31, 407-410. 463 
Kopsida M., Barron G.A., Bermano G., Kong Thoo Lin P., Goua M., 2016. Novel 464 
bisnaphthalimidopropyl (BNIPs) derivatives as anticancer compounds targeting DNA in 465 
human breast cancer cells. Org. Biomol. Chem. 14, 9780-9789. 466 
 22
Leroy B., Hollestelle L.GA.,Minna J.D., Gazdar A.F., Soussi T., 2014.Analysis of TP53 467 
Mutation Status in Human Cancer Cell Lines: A Reassessment. Hum Mutat. 35, 756-765 468 
Li, M. Li, Q., Zhang, Y.H., Tian, Z.Y., Ma, H.X., Zhao, J., Xie, S.Q., Wang, C.J., 2013. 469 
Antitumor effects and preliminary systemic toxicity of ANISpm in vivo  and in vitro. Anti-470 
Cancer Drugs 24, 32-42.  471 
Liang, X., Wu, A.B.,  Xu, Y.F., Xu, K., Liu, J.W., Qian, X.H., 2011. B1, a novel 472 
naphthalimide -based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells 473 
via p53 activation. Investigational New drugs 29, 646-658 474 
Lv, M., Xu, H., 2009. Overview of naphthalimide analogs as anticancer agents. Current 475 
Medicinal Chemistry16, 4797-4813. 476 
Milovic, V., Turchanowa, L., 2003. Polyamines and colon cancer. Biochem. Soc. Trans.31, 477 
381-383. 478 
Morgan, D.M.L., 1999. Polyamines - an overview. Molecular Biotechnology 11, 229-250. 479 
Moschou P.N., Roubelakis-Angelakis, K.A., 2014. Polyamines and programmed cell death. J. 
480 
Exp. Botany 5, 1285-1296 
481 
Noro J., Maciel J., Duarte D., Dias Olival A.C., Baptista C., Cordeiro da Silva A., Alves M.J., 482 
Kong Thoo Lin P., 2015. Evaluation of New Naphthalimides as Potential Anticancer Agents 483 
Against Breast Cancer MCF-7, Pancreatic Cancer BxPC-3 and Colon Cancer HCT-15 Cell 484 
Lines. Organic Chem Curr Res, 4:2 http://dx.doi.org/10.4172/2161-0401.1000144 485 
Oliveira J, Ralton L, Tavares J, Codeiro-da-Silva A, Bestwick CS, McPherson A and Kong 486 
Thoo Lin P (2007) The Synthesis and the in vitro Cytotoxicity studies of 487 
 23
Bisnaphthalimidopropyl polyamine derivatives against Colon Cancer Cells and Parasite 488 
Leishmania infantum"  Bioorganic & Medicinal Chemistry, 15: 541-545 489 
Otsuki, Y., Li, Z.L., Shibata, M.A., 2003. Apoptotic detection methods - from morphology to 490 
gene. Progress in Histochemistry and Cytochemistry 38, 275-339. 491 
Parchment, R.E., Lewwllyn, A., Swartzendruber, D., Pierce, G.B., 1990. Serum amine 492 
oxidase activity contributes to crisis in mouse embryo cell lines. Proc. Natl. Acad. Sci. USA 493 
87, 4340-4344. 494 
Pavlov, V.A., Kong Thoo Lin, P., Rodilla, V., 2001. Cytotoxicity, DNA binding and 495 
localisation of novel bis-naphthalimidopropyl polyamine derivatives. Chemico-Biological 496 
Interactions 137, 15-24. 497 
Ralton, L.D., Bestwick, C.S., Milne, L., Duthie, S., Kong Thoo Lin, P., 2009 498 
Bisnaphthalimidopropyl spermidine induces apoptosis within colon carcinoma cells. 499 
Chemico-Biological Interactions 177, 1-6.  500 
Rebbaa, A., Zheng, X., Chou, P.M., Mirkin, B.L., 2003. Caspase inhibition switches 501 
doxorubicin-induced apoptosis to senescence. Oncogene 22, 2805-2811. 502 
Seiler, N., Knodgen, B., 1985. Determination of polyamines and related compounds by 503 
reversed-phase high-performance liquid chromatography: Improved separation systems. 504 
Journal of Chromatography B-Biomedical Sciences and Applications 339, 45-57. 505 
Seliga, R., Pilatova, M., Sarissky, M., Viglasky, V., Walko, M., Mojzis, J., 2013. Novel 506 
naphthalimide polyamine derivatives as potential antitumor agents. Molecular Biology 507 
Reports 40, 4129-4137. 508 
 24
Schipper, R.G., Penning, L.C., Verhofstad, A.A.J.,  2000. Involvement of polyamines in 509 
apoptosis. Facts and controversies: effectors or protectors? Seminars in Cancer Biology 10, 510 
55-68. 511 
Shen, K., Sun, L.Y., Zhang, H.Y.,  Xu, Y.F., Qian, X.H., Lu, Y.H., Li, Q., Ni, L., Liu, J.W., 512 
2013. ROS-mediated lysosomal-mitochondrial pathway is induced by a novel Amonafide 513 
analogue, 7c, in human He la cervix carcinoma cells. Cancer Letters 333, 229-238. 514 
Stefanelli, C., Pignatti, C., Tantini, B., Fattori, M., Stanic, I., Mackintosh, C.A., Flamigni, F., 515 
Guarnieri, C., Caldarera, C.M., Pegg, A.E., 2001. Effect of polyamine depletion on caspase 516 
activation: a study with spermine synthase-deficient cells. Biochem J. 355, 199-206. 517 
 518 
Tan S.Y., Sun, D.H., Lyu, J.K., Sun, X., Wu, F.S., Li, Q., Yang, Y.Q., Liu, J.X., Wang, X., 519 
Chen, Z., Li, H.L., Qian, X.H., Xu, X.F. 2015. Antiproliferative and apoptosis-inducing 520 
activities of novel-cyclam conjugates through dual topoisomerase (topo) I/II inhibition.  521 
Biorganic and Medicinal Chemistry 23, 5672-5680 522 
 523 
Wallace, H.M., Niiranen, K., 2007. Polyamine analogues as anticancer drugs. Amino acids 524 
33,261-265. 525 
 526 
Wang, K.R., Sun, Q., Ma, CL., Rong, RX., Cao, ZR., Wang, XM., Li, XL. 2016. Substituent 527 
effects on cytotoxic activity, spectroscopic property, and DNA binding property of 528 
napththalimide derivatives. Chemical Biology & Drug Design 87, 664-672 529 
 530 
 25
Yang, L., Li, W., Tian, Z., Zhao, J., Wang, C., 2011a. Monoaphthalimide spermidine 531 
conjugate induces proliferation inhibition and apoptosis in Hela cells. Toxicology in Vitro 25, 532 
882-889. 533 
 534 
Yang, L.H., Zhao, J., Zhu, Y.Q., Tian, Z.Y., Wang C.J., 2011b.Reactive oxygen species 535 
(ROS) accumulation induced by mononaphthalimide-spermidine leads to intrinsic and AIF-536 
mediated apoptosis in HeLa cells. Oncology Reports   25,   1099-1107.   537 
   538 
Yuan, Q., Ray, R.M., Johnson, L.R., 2002. Polyamine depletion prevents camptothecin-539 
induced apoptosis by inhibiting the release of cytochrome c. American Journal of Physiology-540 
Cell Physiology 282, 1290-1297. 541 
 542 
Zhang, G. H., An, Y.F., Lu, X., Zhong, H., Zhu, Y.H., Wu, Y.M., Ma, F., Yang, J.M., Liu, 543 
Y.C., Zhou, Z.P., Peng, Y., Chen, Z.F., 2016a. A Novel Naphthalimide Compound Restores 544 
p53 Function in Non-small Cell Lung Cancer by Reorganizing the Bak center dot Bcl-xl 545 
Complex and Triggering Transcriptional Regulation. Journal of Biological Chemistry 291, 546 
4211-4225 547 
Zhang, J., Yang, Y., He, W.Y., Sun, L.M., 2016b. Necrosome core machinery: MLKL. 548 
Cellular and Molecular Life Sciences 73: 2153-2163  549 
Zhao M, Howard EW, Guo Z, Parris AB, Yang X (2017) p53 pathway determines the cellular 550 
response to alcohol-induced DNA damage in MCF-7 breast cancer cells. PLoS ONE 12(4): 551 
e0175121.  552 
 26
Zhu, H., Miao, Z.H., Huang, M., Feng, J-M., Zhang, Z-X., Lu, J-J., Cai, Y-J., Tong, L-J., Xu, 553 
Y-F., Qian, X-H., Ding, J., 2009. Naphthalimides Induce G(2) Arrest Through the ATM-554 
Activated Chk2-Executed Pathway in HCT116 Cells. Neoplasia11, 1226-1234.    555 
 556 
Zou, T.T., Rao, J.N., Guo, X., Rao, J.N., Strauch, E.D., Bass, B.L., Wang, J.Y., 2004. NF-557 
kappa B-mediated IAP expression induces resistance of intestinal epithelial cells to apoptosis 558 
after polyamine depletion. American Journal of Physiology-Cell Physiology 286, 1009-18.559 
 27
 560 
Figure Legends 561 
 562 
Fig 1. Structure of Bisnaphthalimidopropylspermidine (BNIPSpd) 563 
 564 
Fig 2. Cell growth (A) and cell death (B) were determined following exposure to DMSO (), 565 
1M (), 5M () and 10 M () BNIPSpd. Cell counts were determined by microscopy, 566 
with trypan blue staining used to indicate loss of membrane integrity. Data are means ± SD (n 567 
>6). *P<0.05, **P < 0.01, ***P < 0.001 v. respective time point for DMSO control. 568 
 569 
Fig. 3. DNA damage. Alkaline SCGE followed by visual ‘comet’ scoring was used to determine 570 
DNA single strand breaks after exposure to BNIPSpd. Data are means ± SD (n=3), ***P<0.001 571 
v. respective time point for DMSO control. 572 
 573 
Fig 4. Effect of BNIPSpd exposure on plasma membrane phosphatidylserine labelling relative 574 
to membrane damage.  Cells were treated with BNIPSpd for 6 (A) and 24h (B). Cells labelled 575 
with Annexin-V-FITC but resistant to PI uptake (Annexin-V+) represent those with plasma 576 
membrane extracellular surface exposed phosphatidylserine without plasma membrane 577 
damage and those stained with both Annexin-V-FITC and  PI (Annexin-V+/ PI+) also have 578 
damaged plasma membranes. Data was obtained by flow cytometry and 10,000 events were 579 
analysed per sample. Data are means ± SD (n=3) * P<0.05, ** P = 0.002,***P<0.001 for 580 
increases v. DMSO control. 581 
 582 
 28
Fig 5. Detection of the ‘active’ form of caspase-3.  The level of active caspase-3 expression 583 
was immuno-flow cytometrically determined 4, 12 and 24h after treatment with DMSO and 1, 584 
5 and 10 M BNIPSpd. 10,000 events were analysed per sample. Data are means ±SD (n=6). 585 
* P=0.05 or *** P<0.001 for comparison v. the respective DMSO control.  586 
 587 
Fig 6. The relationship between general (pan)-caspase activity and membrane damage.  FAM-588 
VAD-FMK FLICA labelling with PI co-staining was used to flow cytometrically assess the 589 
level of caspase activity relative to membrane damage within 8h of treatment with BNIPSpd. 590 
The median fluorescence intensity from FAM-VAD-FMK FLICA labelling was used as a 591 
marker of cellular pan-caspase activity (A). The proportion of cells with FAM-VAD-FMK 592 
FLICA but no PI fluorescence (C+), co-fluorescing with FAM-VAD-FMK FLICA and PI 593 
(C+, PI+) , fluorescing only due to  PI (PI+) or showing no fluorescence with FAM-VAD-594 
FMK FLICA and PI (NR)  was used to establish the relationship between caspase activity and 595 
the occurrence of membrane damage (B) the latter as indicated by heightened PI fluorescence. 596 
10,000 events were analysed per sample. Data are means ±SD (n=3). * P<0.05 or *** 597 
P<0.001 for comparison v. the staining within the respective DMSO control. 598 
 599 
Fig 7. ‘Apoptotic’ DNA fragmentation. Sub G1 (hypodiploid) DNA content (A), as an 600 
indicator of apoptotic DNA fragmentation, was determined from flow cytometric analysis of 601 
PI staining using ModFit LT software (Verity Software House, ME, USA). Cells were treated 602 
with DMSO or BNIPSpd. Data  are means ± SD (n=3). * P<0.05, **P<0.01, *** P<0.001 for 603 
comparison v. the respective DMSO control. Internucleosomal DNA fragmentation (B), 604 
considered a classical feature of apoptosis, was detected by agarose gel electrophoresis 605 
following 24h exposure to DMSO, 10M etoposide (positive control for ladder formation) or 606 
BNIPSpd (1, 5 or 10M). M, markers; C no treatment, D, Solvent (DMSO); E, etoposide. 607 
 29
Data is a representative image from one of three experiments (note image split for 608 
presentation). 609 
 610 
Fig 8. Influence on cellular polyamine levels. Effects of polyamine-analogue exposure on 611 
spermine and spermidine was evaluated by HPLC after 12 (A) and 24 (B) h exposure to 612 
BNIPSpd. As an internal control, effects of polyamine analogues are compared with those of 613 
-difluoromethylornithine, DMFO (5mM), an ornithine decarboxylase inhibitor. SPD, 614 
spermidine; SPM, spermine. Data are means ± SD (n=3). *P<0.05 or **P<0.01 v. DMSO 615 
control. 616 
 617 
Fig 9. The influence of caspase inhibitor z-VAD-fmk on DNA fragmentation and cell death. 618 
Cells were pre-treated with the cell permeable pan caspase inhibitor, z-VAD-FMK, prior to 619 
and during exposure to 10 M BNIPSpd.  The extent of DNA ladders (A): lane M, Mw 620 
markers; lane 1, no solvent vehicle or inhibitor; lane 2, DMSO (solvent vehicle) treatment 621 
only; lane  3, z-VAD-FMK; lane 4, BNIPSpd; lane 5, BNIPSpd and z-VAD-FMK lane 6, 622 
etoposide (10M) as positive control for DNA ladder (apoptosis) formation. Note gel-image 623 
splicing is for presentation; (B): the proportion of cells with hypodiploid DNA content, (C): 624 
the effect on cell proliferation and (D): cell death as determined at 24h from start of exposure. 625 
Data is either a representative image from three experiments (A), or are means ± SD (n=3), 626 
data designated by a different letter is significantly different (P<0.05) relative to control or 627 
treatment at the respective time point. 628 
 629 
Fig 10. BNIPSpd induced exogenous, non-cell derived, hydrogen peroxide formation. Using 630 
the phenol red assay hydrogen peroxide concentration was estimated in cell culture medium 631 
containing BNIPSpd. Catalase incubation was used to confirm the presence of hydrogen 632 
 30
peroxide in control and 50BNIPSpd incubations, reducing the absorbance attributed to 633 
resorufin formation to 1% and 5% of non-catalase treatment values respectively. Data are means 634 
(n=3). *P<0.05 v. DMSO control 635 
 636 
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Figure 2  Bestwick et al.  
 
 
 
 
 
 
0
1
2
3
4
C
el
l N
um
be
r (
x1
06
)
0 24 48 72
Time (h)
A
0
25
50
75
100
%
 n
on
-tr
yp
an
 b
lu
e 
st
ai
ne
d 
ce
lls
0 20 40 60 80
Time (h)
B
Figure 3 Bestwick et al.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 Bestwick et al.  
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Figure 5 Bestwick et al.  
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